Close Menu

NIGMS

The research team is developing a computational system for studying the relationship between RNA structure and function.

The firm will use the award to develop silica nanomaterial for use with many sample types, including blood, cultured cells, and pathogens.

The effort, dubbed the National Resource for Translational and Developmental Proteomics, aims to improve on the technology and train others in its use.

The funds will be used to expand the PharmGKB database and support the activities of the Clinical Pharmacogenetics Implementation Consortium.

Vanderbilt received the grant from NIGMS to establish a new personalized medicine and pharmacogenomics research center.

The grant will help create the new core as part of the existing South Carolina Center of Biomedical Research Excellence (COBRE) for cardiovascular disease.

Just One for You

The US National Institute of General Medical Sciences announces a plan to limit grants to already well-supported investigators.

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences will provide up to $2 million per year to renew funding for each of the National Centers for Systems Biology, pending approval of renewal applications, the institute said in an announcement Monday.

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to spend up to $2.4 million in 2015 to fund the Pharmacogenomics Knowledge Base (PharmGKB), a program that supports pharmacogenomics researchers, and has opened

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to fund efforts to develop new resources that investigators focused on pharmacogenomics can use to speed up their research activities or to implement them into practice.

Pages

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.